GILEAD SCIENCES, INC. — Director's Dealing 2017

Aug 31, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2017-08-15

Reporting Person: Meyers James R (EVP Worldwide Commercial Ops)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-15	Common Stock	A	115	$59.7635	Acquired	2830	Direct
2017-08-15	Common Stock	G	115	—	Disposed	2715	Direct
2017-08-15	Common Stock	G	115	—	Acquired	126145	Indirect

Footnotes

F1: Shares were acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan.

F2: Shares gifted to family trust.